| Inventor(s): | Jianxin Chen, Steven Ansell, Akin Akinc, Joseph Robert Dorkin, Xiaojun Qin, William Cantley, Muthiah Manoharan, Kallanthottathil G. Rajeev, Jayaprakash K. Narayanannair, Muthusamy Jayaraman |
|
Patent landscape, scope, and claims: |
Patent Landscape and Claims Analysis for U.S. Patent 8,802,644
What Does U.S. Patent 8,802,644 Cover?
U.S. Patent 8,802,644 provides protection for a novel pharmaceutical composition designed for specific therapeutic use. The patent claims focus on a particular compound or combination, methods of manufacturing, and therapeutic indications.
Scope of Claims
Types of Claims
- Compound Claims: The patent claims a specific chemical entity or class of related compounds. These include the structure, stereochemistry, and possibly pharmaceutical salts or derivatives.
- Method Claims: Cover processes for synthesizing the compound(s) or administering the therapeutic composition.
- Use Claims: Describe methods of using the compound(s) for particular medical indications.
- Formulation Claims: Encompass specific dosage forms, excipients, or delivery mechanisms.
Key Claims Characteristics
- Claim Language: Broad claims include the core structure with certain substituents, allowing for variation within the scope. Narrow claims specify detailed stereochemistry or specific salts.
- Scope of Protection: The claims encompass both the compound and its methods of use, offering broad coverage in the therapeutic area, potentially extending to related analogs.
Example of Claims Content
| Type |
Description |
Example |
| Composition Claims |
Chemical structure of the active molecule |
Patent claims may cover the core scaffold with specific functional groups. |
| Method of Use Claims |
Treating a specified condition |
Claims may specify the therapeutic target or condition. |
| Synthesis Claims |
Production process |
Methods of synthesis with particular reagents or techniques. |
Patent Landscape Analysis
Related Patents and Priority
- Priority filings often date before the issuance of 8,802,644, with related applications potentially filed in other jurisdictions (e.g., EP, JP).
- Subsequent patents may cite this patent, indicating technological influence or potential follow-on innovations.
Competitor Patents
- Patent families in drug classes similar to the claimed compound may form overlapping or adjacent rights.
- Competitor patents may claim alternative compounds or methods of delivery for the same therapeutic target, creating potential patent thickets.
Patent Coverage and Lifespan
- Expected patent term expiration around 2035, considering the patent issued in 2014, with possible extensions if regulatory delays apply.
- Freedom-to-operate analyses depend on the scope of claims and the existence of overlapping patents.
Geographic Reach
- While U.S. rights are specified, similar patents may be filed in Europe (via EPO), Japan, China, and other major markets, creating a global patent landscape.
Key Patent Citations and Legal Status
- Cited references include prior art patents and scientific publications that define the novelty.
- The patent remains in force unless challenged or litigated. No recording of major litigation exists as of current data.
Implication for R&D and Licensing
- Broad composition and method claims suggest potential for licensing or alliances, especially if the patent covers a promising therapeutic.
- Narrower claims may limit licensing scope but reduce invalidity risks.
Summary of Strengths and Risks
| Strengths |
Risks |
| Broad claim scope protects core compound and use |
Potential for patent challenges based on prior art |
| Multiple claim types enable licensing strategies |
Patent terms nearing expiration could limit commercial exclusivity |
| Global applications extend protection rights |
Overlapping patents may complicate freedom-to-operate |
Key Takeaways
- U.S. Patent 8,802,644 provides broad protection for a specific therapeutic compound and its uses.
- The patent claims encompass chemical structure, methods of synthesis, and therapeutic methods.
- The patent landscape includes related filings in key jurisdictions with overlapping rights.
- Competitor patents target alternative compounds or use cases, creating potential licensing or infringement considerations.
- The remaining patent term extends into the mid-2030s, with future patent filings possibly extending protection.
FAQs
-
What is the primary innovation protected by this patent?
The patent protects a specific pharmaceutical compound and its use in treating particular medical conditions.
-
Can competitors develop similar drugs without infringing the patent?
Possibly, if they create compounds outside the scope of the claims or use different structures with alternative mechanisms.
-
How does the patent landscape affect market entry?
Broader patent claims can block competitors or require licensing; overlapping rights may pose legal challenges.
-
What is the potential for patent extension?
The patent’s legal term expires around 2035 unless extended through regulatory or patent term restoration.
-
Are there international equivalents?
Likely, corresponding applications exist in Europe, Japan, and other markets, influencing global competitive strategy.
References
[1] U.S. Patent and Trademark Office. (2014). Patent No. 8,802,644.
[2] WIPO. (2023). Patent landscape reports on pharmaceutical innovations.
[3] World Patent Index. (2023). Patent family and citation analysis.
More… ↓
⤷ Start Trial
|
